Neurologic Complications of Cancer Immunotherapy
Seminars in Neurology · 26.08.2026
DOI: 10.1055/a-2936-4931 ↗Kurz gefasst
Fachartikel in der Zeitschrift Seminars in Neurology, erschienen am 26.08.2026. Verfasst von Alexandra Balshi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Harvard Medical School, Massachusetts, United States, Boston. Die Arbeit nennt 154 Literaturangaben.
Abstract (Originalsprache)
The use of oncologic-directed immunotherapies, including immune checkpoint inhibitors (ICIs) and chimeric antigen receptor T cell (CAR-T) therapy, has risen exponentially in recent years. Although these therapies have been shown to improve long-term survival and quality of life in responsive patients, their nonspecific immune system activation can lead to unanticipated neurotoxicity, among other complications. Immune-related adverse events (irAEs) may involve any location in the entire neuroaxis, posing a diagnostic challenge, and may cause severe, life-threatening complications. ICI-related neurotoxicities may include peripheral neuropathies, myositis, myasthenia gravis, encephalitis, aseptic meningitis, myelitis, and demyelinating disorders. CAR-T therapies carry a comparatively higher risk of neurologic irAEs, most notably immune effector cell–associated neurotoxicity syndrome. In this review, neurotoxicity syndromes associated with ICI and CAR-T therapies are outlined, along with diagnostic approaches and management strategies.
Autor:innen und Institutionen
- Harvard Medical School, Massachusetts, United States, Boston.
- Massachusetts General Hospital, Department of Neurology, Massachusetts, United States, Boston.
- Brigham and Women's Hospital, Department of Neurology, Massachusetts, United States, Boston.
- University of California Irvine, Department of Neurology, California, United States, Orange.
ORCID-Profile: Giovanna S Manzano
Zitieren
APA
Balshi, A., Rajarajan, P., McEntire, C. R. S., & Manzano, G. S. (2026). Neurologic Complications of Cancer Immunotherapy. Seminars in Neurology. https://doi.org/10.1055/a-2936-4931
Vancouver
Balshi A, Rajarajan P, McEntire CRS, Manzano GS. Neurologic Complications of Cancer Immunotherapy. Seminars in Neurology. 2026. doi:10.1055/a-2936-4931
BibTeX
@article{Balshi2026,
author = {Balshi, Alexandra and Rajarajan, Prashanth and McEntire, Caleb R S and Manzano, Giovanna S},
title = {Neurologic Complications of Cancer Immunotherapy},
journal = {Seminars in Neurology},
year = {2026},
doi = {10.1055/a-2936-4931}
}
EUVIMED